Predictive Oncology (POAI) Short Interest Ratio & Short Volume → get a piece of the profit from this land (From True Market Insiders) (Ad) Free POAI Stock Alerts $1.68 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Predictive Oncology Short Interest DataCurrent Short Volume20,600 sharesPrevious Short Volume13,000 sharesChange Vs. Previous Month+58.46%Dollar Volume Sold Short$29,458.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Outstanding Shares4,102,000 sharesFloat Size3,910,000 sharesShort Percent of Float0.53%Today's Trading Volume29,290 sharesAverage Trading Volume488,840 sharesToday's Volume Vs. Average6% Short Selling Predictive Oncology ? Sign up to receive the latest short interest report for Predictive Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPOAI Short Interest Over TimePOAI Days to Cover Over TimePOAI Percentage of Float Shorted Over Time Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Predictive Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202420,600 shares $29,458.00 +58.5%0.5%0.1 $1.43 4/15/202413,000 shares $19,630.00 -49.0%0.3%0.4 $1.51 3/31/202425,500 shares $65,025.00 +129.7%0.7%1.1 $2.55 3/15/202411,100 shares $29,304.00 -37.6%0.3%0.5 $2.64 2/29/202417,800 shares $54,824.00 -31.5%0.5%0.9 $3.08 2/15/202426,000 shares $84,500.00 -19.3%0.7%1.3 $3.25 Get the Latest News and Ratings for POAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/31/202432,200 shares $98,854.00 -8.3%0.8%1.9 $3.07 1/15/202435,100 shares $101,088.00 -33.7%0.9%1.9 $2.88 12/31/202352,900 shares $174,041.00 -15.5%1.4%2.9 $3.29 12/15/202362,600 shares $197,816.00 -26.4%1.6%3.6 $3.16 11/30/202385,000 shares $277,950.00 -13.6%2.2%4.5 $3.27 11/15/202398,400 shares $306,024.00 -4.7%2.5%4.9 $3.11 10/31/2023103,200 shares $309,600.00 -13.5%2.7%4.3 $3.00 10/15/2023119,300 shares $472,428.00 -5.5%3.1%3.9 $3.96 9/30/2023126,300 shares $404,160.00 -32.1%3.2%2.7 $3.20 9/15/2023186,000 shares $597,060.00 -29.7%4.8%2.4 $3.21 8/31/2023264,400 shares $1.14 million -7.8%6.8%2.7 $4.32 8/15/2023286,900 shares $1.37 million -4.9%7.4%2.4 $4.76 7/31/2023301,700 shares $1.75 million -0.5%7.8%2.1 $5.80 7/15/2023303,200 shares $1.77 million +16.3%7.8%1.5 $5.84 6/30/2023260,800 shares $1.27 million +123.7%6.7%1.1 $4.86 6/15/2023116,600 shares $402,270.00 -11.1%3.0%0.5 $3.45 5/31/2023131,100 shares $423,453.00 +40.7%3.4%0.7 $3.23 5/15/202393,200 shares $318,744.00 -49.1%2.5%0.6 $3.42 4/30/2023183,100 shares $520,004.00 +421.7%4.9%1.3 $2.84 4/15/202335,100 shares $266,760.00 -84.3%N/A0.3 $7.60 3/31/2023223,500 shares $73,039.80 +6.9%N/A0.5 $0.33 3/15/2023209,000 shares $68,970.00 -25.3%N/A0.5 $0.33 2/28/2023279,600 shares $119,109.60 +17.1%N/A0.7 $0.43 2/15/2023238,800 shares $103,639.20 -42.8%N/A0.6 $0.43 1/31/2023417,100 shares $221,063.00 +64.0%N/A1 $0.53 1/15/2023254,300 shares $122,699.75 +14.2%N/A0.7 $0.48 12/30/2022222,700 shares $68,279.82 -4.6%N/A0.7 $0.31 12/15/2022233,500 shares $94,007.10 +89.7%N/A0.7 $0.40 11/30/2022123,100 shares $47,405.81 +68.9%N/A0.4 $0.39 11/15/202272,900 shares $19,865.25 -63.7%N/A0.3 $0.27 10/31/2022201,000 shares $54,772.50 +50.9%N/A0.8 $0.27 10/15/2022133,200 shares $40,639.32 -32.4%N/A0.6 $0.31 9/30/2022196,900 shares $70,884.00 +6.4%N/A0.7 $0.36 9/15/2022185,100 shares $71,300.52 +10.4%N/A0.6 $0.39The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. POAI Short Interest - Frequently Asked Questions What is Predictive Oncology's current short interest? Short interest is the volume of Predictive Oncology shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 20,600 shares of POAI short. 0.53% of Predictive Oncology's shares are currently sold short. Learn More on Predictive Oncology's current short interest. What is a good short interest percentage for Predictive Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of Predictive Oncology's floating shares are currently sold short. Is Predictive Oncology's short interest increasing or decreasing? Predictive Oncology saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 20,600 shares, an increase of 58.5% from the previous total of 13,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Predictive Oncology's float size? Predictive Oncology currently has issued a total of 4,102,000 shares. Some of Predictive Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Predictive Oncology currently has a public float of 3,910,000 shares. How does Predictive Oncology's short interest compare to its competitors? 0.53% of Predictive Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Predictive Oncology: Heart Test Laboratories, Inc. (1.12%), NanoVibronix, Inc. (0.10%), Hepion Pharmaceuticals, Inc. (1.19%), Cadrenal Therapeutics, Inc. (0.80%), Telesis Bio, Inc. (0.04%), Shuttle Pharmaceuticals Holdings, Inc. (0.74%), Pasithea Therapeutics Corp. (1.34%), Tenax Therapeutics, Inc. (1.20%), Virios Therapeutics, Inc. (1.24%), Vaccinex, Inc. (2.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Predictive Oncology stock? Short selling POAI is an investing strategy that aims to generate trading profit from Predictive Oncology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Predictive Oncology? A short squeeze for Predictive Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of POAI, which in turn drives the price of the stock up even further. How often is Predictive Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including POAI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Heart Test Laboratories Short Squeeze NanoVibronix Short Squeeze Hepion Pharmaceuticals Short Squeeze Cadrenal Therapeutics Short Squeeze Telesis Bio Short Squeeze Shuttle Pharmaceuticals Short Squeeze Pasithea Therapeutics Short Squeeze Tenax Therapeutics Short Squeeze Virios Therapeutics Short Squeeze Vaccinex Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:POAI) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets